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Abstract
Elderly lady underwent right eye surgery for vitreous clot removal. 72 hours later, she complained of
pain, redness and swelling in operated eye. Endophthalmitis was diagnosed. She was started on
piperacillin/ tazobactam and vancomycin. Evisceration was required. Coagulase negative Staphylococci
were isolated and vancomycin was continued postoperatively. She was discharged on home
intravenous vancomycin therapy. Admitted one week later with painful oral ulcers, fever and diffuse
erythmatous body rash. Vancomycin and other medications were stopped. Investigations revealed
elevated double-stranded deoxyribonucleic acid and anti histone antibodies. Skin biopsy was
suggestive of lupus rash. She was started on 60 mg of oral prednisone, improved dramatically and
discharged to home.
Case presentation
We hereby present an interesting case of an elderly
Hispanic lady with known history of SLE with paroxysmal
Atrial Fibrillation on chronic coumadin therapy. She was
taking only maintenance dose oral prednisone prior to
admission for SLE. She developed right vitreous hemor-
rhage on Coumadin and underwent clot removal surgery.
3 days later, she complained of severe pain, redness and
swelling in right eye. CT scan of orbits was suggestive of
endophthalmitis. She was started on IV piperacillin/
tazobactam and vancomycin. Subsequently, she under-
went evisceration of right eye. Intraoperative cultures were
positive for coagulase negative staphylococcus and vanco-
mycin was continued in the post operative period and at
the time of discharge for a total duration of 2 weeks.
During this hospital stay she was continued on main-
tenance dose of 10 mg of prednisone for SLE.
One week after discharge, she complained of weakness,
dizziness and fever of 101 F at home. No complaints of
chest pain, dyspnoea, nausea or vomiting. No complaints
of dysuria, cough/sputum or diarrhea. At the time of
presentation to hospital, she was febrile, tachycardic and
normotensive. She had painful oral ulcers and rapidly
spreading diffuse erythematous rash all over body. Rest of
systemic examination was within normal limits. Vanco-
mycin and all other medications except prednisone were
stopped. Basic metabolic profile, urine analysis and
white cell count were normal. Blood and urine cultures
were sent, right eye was reevaluated for any residual
infection. Auto immune panel for assessing the lupus
activity was sent. It showed elevated Anti ds DNA
(229 u/ml)/ Anti Histone (119 u/ml)/Anti SSA (1055
u/ml)/ Anti SSB (338 u/ml) while Anti sm/Anti JO1/Anti
RNP/complement remained normal. She also underwent
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biopsy of skin lesions which showed irregular linear and
granular deposition of IgG, IgA and kappa light chain
along the dermoepidermal junction, which supported the
diagnosis of lupus flare up. Her prednisone was increased
to 60 mg/ daily. Within 2 days she showed defervescence
of the symptom complex and was discharged successfully
to home. Her steroids were tapered down to maintenance
dose and she continues to be in remission. Her latest ds
DNA antibody levels were 94 IU/ml (normal <99 IU/ml)
in January 2009.
Discussion
Vancomycin Hydrochloride is a chromatographically
purified tricyclic glycopeptide antibiotic derived from
Amycolatopsis orientalis [1]. It is active against Staphylococci,
including Staphylococcus aureus and Staphylococcus epidermi-
dis (including heterogeneous methicillin-resistant strains)
and Streptococci.
Common adverse effects include nephrotoxcity, ototoxi-
city, neutropenia, Most common cutaneous side effect is
red man syndrome [2]. It is characterized by flushing and
itching in upper torso with hypotension in severe cases
and is caused by histamine release from the mast cells.
Others include Steven Johnson syndrome, vasculitic rash
Figure 1. Anterior view of lower extremities showing the
extension of the macular and petechial rash presented in our
patient. Of note the right shin has signs of chronic venous
stasis.
Figure 2. Anterior view of the thighs showing the macular
rash in the patient, now slowly clearing.
Figure 3. Posterior view of the lower extremities showing
the macular and petechial rash present in the patient.
Figure 4. Immunofluorescence image showing IgA deposits in
the along the dermo epidermal junction. For some technical
reasons on photograph, IgG appears stronger than IgA, when
the opposite was true on the real case.
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and toxic epidermal necrolysis [3]. Lupus flare is one of the
very rare side effects, with isolated similar cases reported in
world literature [4].
Proposed mechanism is that the drug serves as a substrate
for myeloperoxidase, which is activated in polymorpho-
nuclear neutrophils. This interaction causes the formation
of reactive metabolites that directly affect lymphocyte
function. Another is that the genetic differences in an
individual’s P450 system causes drugs to be metabolized
differently, which results in the generation of toxic
metabolites that may facilitate autoimmunity [5].
Classical features include- more common occurrence
in whites and older age groups, infrequent involvement
of renal and CNS, antihistone antibodies are common in
>90%. Complement levels may be normal [6]. Clinically it
can be associated with fevers, myalgias, arthralgias and
a rash. And it usually resolves after several weeks after
discontinuation of the offending medication [7].
Treatment includes stopping the culprit drug and short
course of corticosteroids if the lupus symptoms are too
debilitating as was the case with our patient. Follow up
includes lupus antibody panel, complement levels and
urine analysis. Long term prognosis is good.
Our patient did receive piperacillin/ tazobactum in the
beginning of first admission for a short duration, but it
was discontinued postoperatively, with isolation of
coagulase negative Staphylococcus. She developed lupus
symptoms 7 days postoperatively on vancomycin mono-
therapy. The flare responded promptly to discontinuation
of the same. Thus the probability of piperacillin as the
offending agent remains low.
Conclusions
Vancomycin is a potent antibiotic used in various life
threatening infections. It may lead to lupus flare up very
rarely. Timely recognition of symptoms and discontinua-
tion of the drug is key complete recovery. Systemic steroids
may be needed if initial symptoms were severe.
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Figure 5. Immunofluorescence image showing IgG deposits in
the along the dermo epidermal junction, which supported the
diagnosis of SLE flare up.
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